Arun Kumar Das¹*, Md. Abdus Sattar², SM Sumsuzzoha³ and Shaila Zaman⁴

¹Junior Consultant, Department of Skin and Venereology, 250 Beded General Hospital, Meherpur, Bangladesh

*Corresponding Author: Arun Kumar Das, Junior Consultant, Department of Skin and Venereology, 250 Beded General Hospital, Meherpur, Bangladesh.

Received: June 05, 2023; Published: June 22, 2023

Abstract

Background: In limited lesions of tinea versicolor topical drugs are found as effective; but in extensive cases, systemic drugs are more suitable. Both oral fluconazole and ketoconazole are usually used in Bangladesh in the management of tinea versicolor. But we have very limited comparative information regarding the efficacies of fluconazole and ketoconazole in treating tinea versicolor respectively.

Aim of the Study: The aim of this study was to compare the efficacies of fluconazole and ketoconazole in treating tinea versicolor.

Methods: This comparative observational study was conducted in the department of Skin and Venereology, 250 Baded General Hospital, Meherpur, Bangladesh during the period from May 2022 to April 2023. In total 70 patients with tinea versicolor from several age groups of either gender were enrolled as the study subjects who had continued up to the end of the full tenure of this intervention. All the patients were randomly divided into equal two groups. Patients of group 1(n = 35), received 300 mg fluconazole as a single dose and repeated weekly for 2 weeks and patients of group 2(n = 35), received 400 mg ketoconazole as a single dose and repeated weekly for 2 weeks. Diagnosis of tinea versicolor was made clinically by direct KOH preparation.

Results: In this study, the male-female ratio of the participants was 1.1:1. The mean age of the respondents of group 1 was 31.37 ± 3.28 years which was 30.44 ± 2.88 years in group 2. The mean duration of suffering (In year) was 4.28 ± 0.69 years in group 1 which was found as 4.74 ± 0.54 in group 2. In group 1, at one months’ follow up, in assessing the clinical responses, cured, improved and unchanged cases were found as 66%, 26% and 9% respectively which statuses were found in 57%, 26% and 17% cases respectively in group 2. In assessing the mycological response at 1-month follow-up, in group 1, mycological eradication was found in 71% cases which was found among 60% cases in group 2.

Conclusion: Although, in this current study, in treating tinea versicolor, we found some superiority of fluconazole regarding the efficacy over ketoconazole, but the difference was not remarkable. Both the antifungal azole agents were found as well tolerated.

 Keywords: Tinea; Versicolor; Fluconazole; Ketoconazole; Azole; Efficacy

References

1. Borelli D., et al. “Tinea versicolor: epidemiologic, clinical, and therapeutic aspects”. Journal of the American Academy of Dermatology 25 (1991): 300-305.
2. Klenk AS., et al. “Yeast infections; candidiasis pityriasis (tinea) versicolor”. In: Freedberg IM, Eisen AZ, Wolff K, et al, eds. Dermatology in general medicine. 6^th Vol. 2. New York: McGraw Hill (2003): 2006-2020.
3. Gupta AK., et al. “Pityriasis versicolor”. Dermatology Clinics3 (2003): 413-429.
4. Arndt KA. “Fungal infections”. In: Manual of dermatologic therapeutics. Little, Brown and Company: Boston, (1995): 75-89.
5. Di Silverio D., et al. “Pityriasis versicolor in a new born”. Mycoses 38 (1995): 227-228.
6. Schmidt A. “Malassezia furfur: A fungus belonging to the physiological skin flora and its relevance in skin disorders”. Cutis 59 (1997): 21-24.
7. Hay RJ and Moore M. “Mycology”. In: Rook A, Wilkinson DS, Ebling FJG (eds) Textbook of dermatology. Blackwell Science: Oxford (1998): 1277-1376.
8. Havu V., et al. “A double-blind randomized study to compare the efficacy and safety of terbinafine (Lamisil) with fluconazole (Diflucan) in the treatment of onychomycosis”. British Journal of Dermatology 142 (2000): 97-102.
9. Amer M and the Egyptian Fluconazole Study Group, Fluconazole in the treatment of tinea versicolor. International Journal of Dermatology 36 (1997): 938-946.
10. World Medical Association. World Medical Association Declaration of Helsinki. “Ethical principles for medical research involving human subjects”. Bulletin of the World Health Organization4 (2001): 373 - 374. World Health Organization.
11. Voigt Paul and Axel von dem Bussche. "Enforcement and fines under the GDPR." The EU General Data Protection Regulation (GDPR). Springer, Cham, (2017): 201-217.
12. Begum Sharmin., et al. “A comparative study of oral Ketoconazole versus Itraconazole in the treatment of Tinea versicolor”. Community Based Medical Journal2 (2020): 26-33.
13. , et al. Have also observed almost similar results with more prevalence of cases in males. This probably could be attributed to their occupation and outdoor activities.
14. Singh G., et al. “Clinical pattern of pityriasis versicolor”. Indian Journal of Dermatology, Venereology and Leprology3 (1966): 81-84.
15. Faergemann J. “Pityrosporum infections”. Journal of the American Academy of Dermatology 31 (1994): S18-S20.
16. Rad F., et al. “Randomized comparative clinical trial of Artemisia Sieberi 5% lotion and clotrimazole 1% lotion for the treatment of tinea versicolor”. Indian Journal of Dermatology3 (2008): 115-118.
17. Silva H., et al. “A comparison of itraconazole with ketoconazole, itraconazole, and clotrimazole in the treatment of patients with tinea versicolor”. Current Therapeutic Research - Clinical and Experimental4 (1998): 203-214.
18. Bhogal CS., et al. “Comparative efficacy of Woconazole and itraconazole in the treatment of tinea versicolor: a one-year follow-up study”. Journal of Dermatology10 (2001): 535-539.

Citation

Citation: Arun Kumar Das., et al. “A Comparative Study Between Efficacies of Fluconazole and Ketoconazole in Tinea Versicolor". Acta Scientific Dermatology and Venereology 1.1 (2023): 18-22.

Copyright

Copyright: © 2023 Arun Kumar Das., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.